The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Open accessAbstract
The role of T helper type 1 (Th1) and Th2 cells in tumor immunity was investigated using Th cells induced from ovalbumin (OVA)-specific T cell receptor transgenic mice. Although Th1 cells exhibited stronger cytotoxicity than Th2 cells, both cell types completely eradicated tumors when transferred into mice bearing A20 tumor cells transfected with the OVA gene (A20-OVA). Th1 cells eradicated the tumor mass by inducing cellular immunity, whereas Th2 cells destroyed the tumor by inducing tumor necrosis. Both Th1 and Th2 cells required CD8+ T cells to eliminate tumors, and neither of these cells were able to completely eliminate A20-OVA tumors from T and B cell–deficient RAG2−/− mice. Mice cured from tumors by Th1 and Th2 cell therapy rejected A20-OVA upon rechallenge, but CD8+ cytotoxic T lymphocytes were induced only from spleen cells prepared from cured mice by Th1 cell therapy. Moreover, we demonstrated that Th1 and Th2 cells used distinct adhesion mechanisms during tumor eradication: the leukocyte function-associated antigen (LFA)-1–dependent cell–cell adhesion step was essential for Th1 cell therapy, but not for Th2 cell therapy. These findings demonstrated for the first time the distinct role of antigen-specific Th1 and Th2 cells during eradication of established tumors in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in Vivo
Murphy, K. M., Heimberger, A. B., & Loh, D. Y. (1990) · Science · doi:10.1126/science.2125367 · Cited by 1,735
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Murine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues
Austrup, F., Vestweber, D., Borges, E., Löhning, M., Bräuer, R., Herz, U., Renz, H., Hallmann, R., Scheffold, A., Radbruch, A., et al. (1997) · Nature · doi:10.1038/385081a0 · Cited by 725
Sad, S., Marcotte, R., & Mosmann, T. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90051-9 · Cited by 684
Tahara, H., Zeh, H. J., Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Wolf, S. F., Robbins, P., & Lotze, M. T. (1994) · PubMed · Cited by 326
Greenberg, P. D., Kern, D. E., & Cheever, M. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1122 · Cited by 292
Immunotherapy of cancer with dendritic-cell-based vaccines
Gilboa, E., Nair, S. K., & Lyerly, H. K. (1998) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050465 · Cited by 287
Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, K., Nakayama, E., Taniyama, T., & Sakata, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9456 · Cited by 282
North, R. J., & Bursuker, I. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.5.1295 · Cited by 253
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F. R., & Bevan, M. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.603 · Cited by 219
Allione, A., Consalvo, M., Nanni, P., Lollini, P., Cavallo, F., Giovarelli, M., Forni, M., Gulino, A., Colombo, M. P., & Dellabona, P. (1994) · PubMed · Cited by 162
Santamaria‐Babí, L. F., Moser, R., Soler, M. T. P., Picker, L. J., Blaser, K., & Hauser, C. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1543 · Cited by 143
Gene Transfer as Cancer Therapy
Dranoff, G., & Mulligan, R. C. (1995) · Advances in immunology · doi:10.1016/s0065-2776(08)60624-0 · Cited by 135
Pericle, F., Giovarelli, M., Colombo, M. P., Ferrari, G., Musiani, P., Modesti, A., Cavallo, F., Pierro, F. D., Novelli, F., & Forni, G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5659 · Cited by 131
Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state
Fujimoto, T., Duda, R. B., Szilvasi, A., Chen, X., Mai, M., & O’Donnell, M. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5619 · Cited by 118
Strassmann, G., Jacob, C. O., Evans, R., Beall, D., & Fong, M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3674 · Cited by 112
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
Li, Y., Hellström, K. E., Newby, S. A., & Chen, L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.2.639 · Cited by 79
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses
Hamaoka, T., & Fujiwara, H. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90186-1 · Cited by 58
Application of interleukin 12 to antitumor cytokine and gene therapy
Nishimura, T., Watanabe, K., Yahata, T., Ushaku, L., Ando, K., Kimura, M., Saiki, I., Uede, T., & Habu, S. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051033 · Cited by 40
Self-citationTanaka, Y., Kobayashi, K., Takahashi, A., Arai, I., Higuchi, S., Otomo, S., Habu, S., & Nishimura, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.5088 · Cited by 38
Self-citationShen, Y., & FUJIMOTO, S. (1996) · PubMed · Cited by 38
Cellular and Molecular Mechanisms Underlying IL‐12‐Induced Tumor Regression
Fujiwara, H., Clark, S., & Hamaoka, T. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52679.x · Cited by 34
Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen-specific Th1 or Th2 cells
Ohta, A., Sato, N., Yahata, T., Ohmi, Y., Santa, K., Sato, T., Tashiro, H., Habu, S., & Nishimura, T. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00152-x · Cited by 31
Self-citationKuge, S., Watanabe, K., Makino, K., et al. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03030.x · Cited by 23
Nishimura, T., Takeuchi, Y., Gao, X., Urano, K., & Habu, S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.7.2094 · Cited by 13
Self-citation
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
Knutson, K. L., & Disis, M. L. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0653-2 · Cited by 682
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., & Woller, N. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2686-7 · Cited by 549
Finke, J. H., Rini, B., Ireland, J., Rayman, P., Richmond, A., Golshayan, A., Wood, L., Elson, P., Garcia, J., Dreicer, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5212 · Cited by 492
Metadata
- Authors
- Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., & Ohta, A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-09-06
- Volume
- 190
- Issue
- 5
- Pages
- 617-628
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1508865104
- Cited by
- 468
- References
- 34
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.